Naltrexone/bupropion

From WikiMD's WELLNESSPEDIA

Chemical structures of Bupropion and Naltrexone

Naltrexone/bupropion is a combination medication used for weight management in adults. It combines two drugs: naltrexone, an opioid antagonist, and bupropion, an atypical antidepressant. This combination is marketed under the brand name Contrave, among others.

Mechanism of Action[edit]

Naltrexone and bupropion work together to affect the central nervous system. Naltrexone is primarily used to manage alcohol and opioid dependence by blocking the euphoric effects of these substances. Bupropion, on the other hand, is used to treat depression and aid in smoking cessation. When combined, these drugs influence the hypothalamus and the mesolimbic dopamine circuit, which are involved in regulating appetite and energy balance.

Clinical Use[edit]

Naltrexone/bupropion is prescribed as part of a comprehensive weight management program that includes a reduced-calorie diet and increased physical activity. It is indicated for use in adults with an initial body mass index (BMI) of 30 kg/m_ or greater (obese) or 27 kg/m_ or greater (overweight) in the presence of at least one weight-related comorbid condition such as hypertension, type 2 diabetes mellitus, or dyslipidemia.

Side Effects[edit]

Common side effects of naltrexone/bupropion include nausea, constipation, headache, vomiting, dizziness, insomnia, dry mouth, and diarrhea. Serious side effects may include seizures, increased blood pressure, and liver damage. Patients are advised to monitor for any unusual changes in mood or behavior, as bupropion can increase the risk of suicidal thoughts and behaviors.

Contraindications[edit]

Naltrexone/bupropion is contraindicated in patients with uncontrolled hypertension, seizure disorders, a history of anorexia nervosa or bulimia, and those undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs. It is also contraindicated in patients who are currently dependent on chronic opioids or opiate agonists, or who are in acute opiate withdrawal.

Related Pages[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.